Ayala Pharmaceuticals Inc (ADXS)

[samk]

all this talk about management performance and share price...
the share price depends only what powers decide to do.
In our case the management did a good job (not talking about RSU's):
forged collaborations with Merck, Astra and Amgen just lately. selling shares at 13.5 was not planned to bring the stock down either.

ADXs just opened production facilities, probably for a good reason...
But all those talks about management always appear before or when shorting intensifies. to cover shorts, or accumulate at lower price needs to short more by employing tactics by selling small blocks(100 shares) and buying 500-1000 at a time, which allows them to decrease short position, or accumulate cheap stock.

With everything we have done so far, the stock should not go lower than $13.5, if it was not shorted and manipulated, period.
the management has nothing to do with this.
just a word about news of 'investigation' by ambulance chaser. even if this 'investigation' would amount to the lawsuit, it should not reflect on the stock price , as all claims against the management covered by insurance.
BTW, if ADXS will get an BO offer, it's because of its science and people...